Long-acting injectables help patients overcome stigma and adherence barriers in HIV care, explained Matthew H. Herrmann, MD, AAHIVS.
Matthew H. Herrmann, MD
Advertisement
Matthew H. Herrmann, MD, AAHIVS, is an infectious diseases specialist and internist at AIDS Healthcare Foundation, Westside Healthcare Center, Beverly Hills, CA.
Articles by Matthew H. Herrmann, MD
Advertisement
Latest Updated Articles
How Long-Acting Injectables Are Changing HIV CareSeptember 2nd 2026
Advertisement
Advertisement
Trending on AJMC
1
Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote
2
Health System Pharmacies Keep Patients on GLP-1 Therapy
3
Melatonin Use Linked to Small REM Sleep Reduction in Children
4
Opposing Sides of 340B Debate Converge on Data Clearinghouse, Patient Definition
5